Pangaea Presenting at 5th Annual McKinsey Cancer Center Symposium
Venue: Novotel Madrid Campo de las Naciones, Madrid, Spain
Session: Oncology Rewired – Improving Patient Lives with Digital Health
Discover how the UK’s NHS applied Pangaea’s product to find 6x more undiagnosed and miscoded cachectic cancer patients compared to natural language processing (NLP) approaches. This led to improved resource optimization and halved treatment costs, saving £1 billion annually. Additionally, this benefited pharmaceutical sponsors by expanding the pool of potentially suitable patients for their trials and therapies six-fold while preserving patient privacy. Pangaea has demonstrated success across oncology conditions, such discovering more lung and ovarian cancer patients suitable for screening, and fosters financially sustainable and scalable collaboration between both industries, revolutionizing patient care.
Please register here to join the panel discussion.